MedPlus Health Services Limited (NSE:MEDPLUS)

MedPlus Health Services Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	62,930	61,361	56,249	45,576	37,793	30,693
Revenue Growth (YoY)	4.94%	9.09%	23.42%	20.59%	23.13%	6.92%
Cost of Revenue	46,841	46,656	44,105	35,758	29,938	24,314
Gross Profit	16,089	14,705	12,143	9,818	7,855	6,379
Selling, General & Admin	8,157	7,441	6,508	5,565	4,010	3,405
Other Operating Expenses	2,318	2,263	1,970	1,476	1,025	737.6
Operating Expenses	13,083	12,202	10,721	8,857	6,228	5,025
Operating Income	3,006	2,502	1,423	960.92	1,627	1,353
Interest Expense	-1,090	-1,026	-964.33	-830.27	-664.28	-536.17
Interest & Investment Income	259.91	259.91	209.36	277.88	137.32	77.94
Currency Exchange Gain (Loss)	0.27	0.27	0.36	0.9	-0.08	-1.64
Other Non Operating Income (Expenses)	147.45	25.65	25.21	23.65	42.3	19.81
EBT Excluding Unusual Items	2,324	1,762	693.29	433.08	1,142	913.13
Gain (Loss) on Sale of Investments	-	-	-	-	-	0.3
Gain (Loss) on Sale of Assets	-8.47	-8.47	-4.53	-3.54	-1.82	-0.98
Asset Writedown	66.67	66.67	45.22	42	38.18	23.79
Other Unusual Items	-	-	-	-	-	12.78
Pretax Income	2,394	1,833	734.43	471.63	1,179	950.98
Income Tax Expense	443.84	330.56	78.66	-29.42	232.27	319.87
Earnings From Continuing Operations	1,950	1,502	655.77	501.05	947.16	631.11
Minority Interest in Earnings	0.47	0.89	-1.04	-3.42	10.86	7.47
Net Income	1,951	1,503	654.73	497.63	958.02	638.58
Net Income to Common	1,951	1,503	654.73	497.63	958.02	638.58
Net Income Growth	94.65%	129.59%	31.57%	-48.06%	50.02%	2829.27%
Shares Outstanding (Basic)	120	120	119	119	112	104
Shares Outstanding (Diluted)	120	120	120	120	112	108
Shares Change (YoY)	-0.11%	-0.00%	0.31%	6.38%	3.82%	0.17%
EPS (Basic)	16.30	12.57	5.48	4.17	8.55	6.13
EPS (Diluted)	16.25	12.52	5.45	4.17	8.52	5.89
EPS Growth	94.93%	129.72%	30.70%	-51.06%	44.65%	2815.86%
Free Cash Flow	5,080	4,810	593.38	-785.97	521.68	-513.66
Free Cash Flow Per Share	42.34	40.07	4.94	-6.57	4.64	-4.74
Gross Margin	25.57%	23.96%	21.59%	21.54%	20.78%	20.78%
Operating Margin	4.78%	4.08%	2.53%	2.11%	4.30%	4.41%
Profit Margin	3.10%	2.45%	1.16%	1.09%	2.54%	2.08%
Free Cash Flow Margin	8.07%	7.84%	1.05%	-1.73%	1.38%	-1.67%
EBITDA	3,728	3,239	2,085	1,412	1,867	1,520
EBITDA Margin	5.92%	5.28%	3.71%	3.10%	4.94%	4.95%
D&A For EBITDA	721.88	736.28	661.89	450.6	240.1	166.82
EBIT	3,006	2,502	1,423	960.92	1,627	1,353
EBIT Margin	4.78%	4.08%	2.53%	2.11%	4.30%	4.41%
Effective Tax Rate	18.54%	18.04%	10.71%	-	19.69%	33.64%
Revenue as Reported	63,538	61,847	56,649	46,037	38,106	30,908
Advertising Expenses	-	179.01	252.1	112.6	67.82	16.78

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.